Perkins Capital Management’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
AC
SCM
B
Perkins Capital Management's LUNG Position: Q2 2026 in Review
Perkins Capital Management reduced its Pulmonx (LUNG) stake by 3.7% in Q2 2026, selling an estimated $2.07K and leaving 39,500 shares worth $51.4K. The position accounts for 0.04% of the portfolio, ranked #77.
Perkins Capital Management first reported a position in LUNG in Q2 2025 and has held it in 5 quarters since. The position peaked at $108K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.
- Perkins Capital Management held 39,500 shares of Pulmonx worth $51.4K as of Q2 2026.
- Perkins Capital Management sold 1,500 Pulmonx shares in Q2 2026, an estimated $2.07K.
- Pulmonx made up 0.04% of Perkins Capital Management's portfolio in Q2 2026, its #77 holding.
- Perkins Capital Management first reported a position in Pulmonx in Q2 2025 and has held it in 5 quarters since.
- Perkins Capital Management's Pulmonx position peaked at $108K in Q4 2025.
- 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.
Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.